Is the US prepared to deal with another pandemic or widespread health crisis?

Is the US Prepared for Another Pandemic? A Mixed—and Increasingly Concerning—Picture

This is a question with substantial debate among public health experts, but the weight of recent evidence suggests significant erosion in US pandemic readiness, even as some technological capabilities improve.

Reasons for Concern

Federal workforce and funding cuts: CDC lost approximately one quarter of its civilian workforce between fiscal years 2024 and 2026, with reductions spanning global health, health promotion, scientific research, and communications. The Health Resources and Services Administration also similarly lost approximately one quarter of its staff.

Terminated funding streams: The March 2025 termination of more than $12 billion in COVID-19-era grants had been broadened to support infectious disease monitoring, laboratory capacity, emergency preparedness, and mental health services. While court orders blocked terminations for plaintiff states and the District of Columbia, litigation remained unresolved through year's end, creating sustained uncertainty for preparedness planning.

Vaccine R&D setbacks: There was also the cancellation of nearly $500 million in contracts funding mRNA vaccine research and development in August 2025, described as a potential disruption to the research, development, and deployment of countermeasures needed for the next public health emergency.

Reduced global surveillance: Critically, the U.S. formally completed its withdrawal from the World Health Organization in January 2026, reducing access to global data sources that support outbreak tracking and response. Additionally, the dissolution of USAID and reductions to CDC's global health programs have further curtailed the international disease surveillance capabilities that historically served as an early warning system for U.S. clinical and public health responders.

No central coordinating body: The White House Office of Pandemic Preparedness and Response Policy—created to coordinate federal response—had its head, Gerald Parker, resign in 2025, leaving the office with no employees.

State-level readiness is uneven: A 2026 assessment found 20 states in the high-performance tier, 17 states and the District of Columbia in the middle-performance tier, and 13 states in the low-performance tier for emergency preparedness. The broader context includes the fact that in 2025, the country faced the most severe flu season in nearly a decade, rising measles outbreaks, continued H5N1 avian influenza activity, and a growing number of extreme weather events—all while federal systems built over decades to help states prepare for and respond to emergencies came under significant strain.

Proposed budget cuts: The FY2026 budget proposal included dramatic reductions, with the administration's proposed FY2026 budget cutting CDC's total funding by 53 percent, including the Public Health Emergency Preparedness program—the cooperative agreement that funds state and local readiness infrastructure—facing a proposed 52 percent reduction.

Reasons for Cautious Optimism

Not all the news is negative. At a 2026 scientific meeting, experts noted that tools to confront future pandemics—including advanced surveillance, artificial intelligence, new antiviral therapies and next-generation vaccines—are improving rapidly, but the systems needed to use those tools consistently and effectively are still catching up. There's also been progress in predictive capability: a shift from reacting to pandemics to predicting them, with researchers using AI to analyze global genomic data to identify how viruses are likely to evolve before dangerous variants emerge.

Global Context

The problem isn't limited to the US. A global assessment found that the 100-day target for pandemic response is not yet achievable in many areas, with significant gaps persisting across diagnostics, therapeutics, vaccines and the systems required to deliver them rapidly and equitably. Globally, overall investment in pandemic countermeasure R&D continued to decline through FY2024, with the steepest impacts seen in therapeutics.

Bottom Line

Based on current evidence, the consensus among public health researchers and organizations tracking this issue is that the US is less prepared now than it was a few years ago, largely due to deliberate funding and staffing cuts at federal agencies, withdrawal from international health cooperation (WHO), and disruption to vaccine research pipelines—even as underlying scientific and technological tools for pandemic response continue to advance. The gap between capability (what's technologically possible) and capacity (what the system can actually deploy) appears to be widening rather than closing.